You just read:

OncoSec to Present TAVO™ Immune Biomarker Data Associated with Positive Clinical Response from Ongoing KEYNOTE Studies at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting

News provided by

OncoSec Medical Incorporated

Nov 05, 2019, 08:30 ET